Focus and Coverage
The Journal of Pharmacology and Pharmacotherapeutics (JPP) is an open access, peer reviewed journal which publishes high-quality articles pertaining to basic research and clinical studies in the domains of Pharmacology and Pharmacotherapeutics. Articles are freely accessible online in perpetuity under a Creative Commons License.
Contents from Current Issue
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundHand hygiene is the key to prevent spread of infections in any health care setting. It is vital to understand and assess health care students knowledge and understanding towards hand hygiene so that effective infection control can be ensured….Read Original Source
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundOpioids have been an integral part of pain management for many years. With the increasing global burden of opioid dependence, the development of non-opioid therapies provides a new framework for pain management. Suzetrigine is a stepping stone …Read Original Source
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundDoxorubicin (DX)-induced cardiotoxicity involves dose- and time-dependent myocardial injury driven by oxidative stress, mitochondrial dysfunction, and disrupted topoisomerase IIβ signaling, leading to progressive left ventricular dysfunction and …Read Original Source
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundThe utilisation of vasoconstrictors like clonidine with local anaesthetics during subarachnoid blockade is a well-established practice.PurposeThis study aims to compare the effects of oral clonidine premedication versus placebo on the onset and …Read Original Source
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundCancer is a complex condition defined by the uncontrolled growth and proliferation of cells. Brain neoplasms, both primary and secondary, present a rising global health burden. Newer classification integrates key molecular markers; IDH mutation, …Read Original Source
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundIn Serbia, as well as worldwide, clinical trials are a significant and unavoidable part of the development of new medicines. There is limited research on prospective risk management in clinical trials in Serbia, underscoring the need for …Read Original Source
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. A case of colchicine overdose of 27 mg, or 0.27 mg/kg (weight 99.8 kg), is reported to assess the potential symptoms seen with this type of toxicity and analyze a prospective treatment for successful outcomes. A 74-year-old man unintentionally ingested …Read Original…
Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundAutoimmune and inflammatory diseases, such as rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, and psoriasis, are typified by immune dysregulation resulting in chronic inflammation and progressive tissue injury. Standard …Read Original Source
